1 minute read
Jan. 17, 2022

Compound 3: a Vanin-1 Inhibitor

“compound 3”

vanin-1 pantetheinase inhibitor preclinical candidate for IBD from HTS + SBDD Journal of Medicinal Chemistry Pfizer, Cambridge, MA + Groton, CT

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in